Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Current Radiopharmaceuticals|October 6, 2012
Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumabXimena Camacho, María Fernanda García, Victoria Calzada, et al.Current Radiopharmaceuticals|November 15, 2011
Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studiesMaria Fernanda Garcia, Ximena Camacho, Victoria Calzada, et al.Current Radiopharmaceuticals|November 29, 2014
Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibodyMaría F García, Victoria Calzada, Ximena Camacho, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2022
T908 Polymeric Micelles Improved the Uptake of Sgc8-c Aptamer Probe in Tumor-Bearing Mice: A Co-Association Study between the Probe and Preformed NanostructuresRomina Castelli, Manuel Ibarra, Ricardo Faccio, et al.Current Radiopharmaceuticals|January 28, 2012
A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumabVictoria Calzada, Xiuli Zhang, Marcelo Fernandez, et al.Bioorganic & Medicinal Chemistry|January 17, 2017
Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of conceptVictoria Calzada, María Moreno, Jessica Newton, et al.Oncology|January 19, 2013
[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma modelXimena Camacho, María Fernanda García, Victoria Calzada, et al.Anti-Cancer Agents in Medicinal Chemistry|March 11, 2016
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging AgentsVictoria Calzada, María Fernanda García, Luis Michel Alonso-Martínez, et al.Biophysical Reviews|January 21, 2022
Sequence-dependent structural properties of B-DNA: what have we learned in 40 years?Gabriela da Rosa, Leandro Grille, Victoria Calzada, et al.Pageof 2